Chlud K
Z Rheumatol. 1978 May-Jun;37(5-6):174-69.
The experimental investigation is divided into 3 parts: Firstly, it was assessed that cyclophosphamide (Cp) in different dosages was well tolerated locally when injected into the knee joint of normal rabbits as compared to saline controls on the basis of histology and cell count determination of the injected joints. In a second series of experiments a hyperimmune arthritis (HIA) was produced in rabbits by systemic administration of albumin, complete Freund's adjuvant and intraarticular stimulus by ovalbumin. Histological examination of synovial membranes reveal alterations similar to those of human rheumatoid arthritis on the 7th day after stimulus. Further experiments were aimed at assessing if Cp exerted an inhibitory effect on the 7 day old HIA. Cp in a dosage of 10 mg has been applied intraarticularly in various intervals prior, simultaneously and after the elicitation of HIA. It could be demonstrated that Cp led to a reduction of the number of lymphocytes, plasma cells and fibroblasts in the synovial membrane, the inhibitory effect on fibroblasts was bound to its administration around the point of HIA elicitation, an even stronger inhibition of lymphocytes and plasma-cells was only to be expected when Cp was applied 48 hours after ovalbumin challenge. Unwanted reactions in the course of Cp administration such as superficial and deep necrosis as well as damage of blood vessels in the synovial membrane combined with minor inhibition of lymphocytes and plasma cells were encountered when Cp was injected 120 hours after HIA elicitation. These new experimental results lead to the conclusion that efficacy and unwanted reactions during Cp administration are related to a local activation of the substance in the inflammatory milieu of HIA. Furthermore we were able to demonstrate that even the sole application of Cp if injected shortly before immigration of lymphocytes into the synovial tissue led to a marked suppression of almost all histological parameters of HIA. Our experimental findings strongly support the importance of lymphocytes and plasma cells being inactivated for the successful treatment of adult rheumatoid arthritis. They grow to consider the formation of necrosis and damage of blood vessels as sequelae of too fast a local activation of Cp in the inflammatory tissue.
首先,基于对注射关节的组织学和细胞计数测定,评估了与生理盐水对照组相比,将不同剂量的环磷酰胺(Cp)注射到正常兔膝关节时,其在局部具有良好的耐受性。在第二系列实验中,通过全身给予白蛋白、完全弗氏佐剂以及用卵清蛋白进行关节内刺激,在兔身上诱发了超免疫性关节炎(HIA)。刺激后第7天,滑膜的组织学检查显示出与人类类风湿性关节炎相似的改变。进一步的实验旨在评估Cp是否对7日龄的HIA产生抑制作用。在诱发HIA之前、同时及之后的不同时间间隔,关节内应用了10mg剂量的Cp。结果表明,Cp导致滑膜中淋巴细胞、浆细胞和成纤维细胞数量减少,对成纤维细胞的抑制作用与其在HIA诱发点周围的给药有关,只有在卵清蛋白攻击后48小时应用Cp时,才有望对淋巴细胞和浆细胞产生更强的抑制作用。当在HIA诱发后120小时注射Cp时,在Cp给药过程中出现了如浅表和深部坏死以及滑膜血管损伤等不良反应,同时对淋巴细胞和浆细胞的抑制作用较小。这些新的实验结果得出结论,Cp给药期间的疗效和不良反应与该物质在HIA炎症环境中的局部激活有关。此外,我们能够证明,即使仅在淋巴细胞迁入滑膜组织之前不久注射Cp,也会导致HIA几乎所有组织学参数的显著抑制。我们的实验结果有力地支持了淋巴细胞和浆细胞失活对于成功治疗成人类风湿性关节炎的重要性。他们逐渐认为坏死的形成和血管损伤是炎症组织中Cp局部激活过快的后遗症。